Estée Lauder (EL) Q4 2026 Earnings Call Transcript

Estée Lauder posted strong fiscal 2026 results: organic net sales grew 3% and adjusted diluted EPS rose 66% to $2.51, alongside gross margin expansion of 150bps to 75.5% and operating margin expansion of 320bps to 11.2%. The company raised fiscal 2027 guidance to organic sales growth of 3%–5% and operating margin of 12.7%–13.5%, with adjusted EPS of $3.10–$3.35, while projecting ~$1.2B of annual PRGP gross benefits and $1.3B–$1.4B operating cash flow. Management also highlighted strong momentum in Mainland China (9% organic growth; market share gains) and online sales reaching an all-time record at 34% of reported sales (+3pp). Overall, improved profitability, cash generation ($1.8B OCF; free cash flow $1.32B) and credible margin run-rate support a constructive outlook despite localized disruption in EUKEM from Middle East conflict and ongoing Hair Care (Aveda salon channel) challenges.

Analysis

EL’s rerating case is now less about “turnaround optionality” and more about whether the company can sustain a higher baseline margin while re-accelerating the top line. The market will likely reward the cleaner operating model in the near term, but the real signal is that the earnings power is becoming less dependent on any single geography: that reduces tail-risk discounting and should support a higher multiple if execution holds through the first-half innovation cadence.

The second-order winner set is broader than EL itself. SHOP, META, and WPP are small but real beneficiaries if the company continues shifting DTC, media, and conversational commerce spend toward a more automated stack; that is a steady, multi-quarter spending stream rather than a one-off implementation win. Conversely, prestige peers with weaker China or fragrance positioning should see relative pressure if EL’s share gains persist, especially where shelf-space and marketing dollars are being reallocated toward faster-turning brands.

The main bear case is that the numbers are still a cost-led bridge, not yet a pure demand-led inflection. FCF guidance stepping down despite better earnings tells you working capital and restructuring remain a drag, so the cleanest falsifier is any slip in North America or travel retail sell-through translating into weaker-than-guided first-half growth. If the stock jumps on the print, the move is only durable if EL can hold organic growth above 3% and show that gross margin expansion is not peaking before the full PRGP run-rate lands in 2028.

Contrarian view: consensus may be underestimating how much of the margin story is already visible in the model, while overestimating how fast the top line can broaden. The upside surprise is likely less about another giant beat and more about reduced volatility, which supports a slower but steadier multiple expansion. That argues for using strength tactically rather than treating this as an all-clear on the equity just yet.

Key Decisions for Investors

• Long EL on a 1-3 month horizon, but size modestly: the cleaner margin path and reduced transformation risk support a higher floor; add on any post-earnings pullback rather than chasing a gap-up.
• Pair trade: long EL / short a weaker prestige-beauty peer basket or sector proxy if available, on the view that EL is now the share-gain story in China and North America while peers with less diversified growth remain more dependent on promotions.
• Small tactical long META and SHOP against EL’s AI/DTC spend ramp over 3-6 months: the thesis is not huge revenue transfer, but incremental budget share as EL pushes conversational commerce and Shopify rollout.
• Watch WPP as a medium-term beneficiary; if campaign volumes keep rising into fiscal 2027, consider a long on any post-results weakness, but only if management confirms advertising spend is not being cut elsewhere.
• Set a falsifier alert: if Q1/Q2 organic growth prints below the low end of 3%-5% or North America reverts to decline, cut the bullish EL thesis and reassess margin-driven multiple support.